[1D10-13] Medical RI Production 1

Wed. Mar 16, 2022 2:45 PM - 3:50 PM Room D

Chair: Keita Nakano (JAEA)

2:45 PM - 3:00 PM

[1D10] Medical RI production using domestic nuclear infrastructures for self-sustenance

(1)Overall scope and plan

*Naoyuki Takaki¹, Yumi Kawata², Anri Inaki³, Kazuta Kobayashi⁴, Shigetaka Maeda⁵ (1. Tokyo City University, 2. NucMed, 3. Kanazawa University, 4. Mitsubishi Heavy Industry, 5. Japan Atomic Energy Agency)

3:00 PM - 3:15 PM

[1D11] Medical RI production using domestic nuclear infrastructures for self-sustenance

(2)Japan market size estimation on Ac225 radiopharmaceuticals

*Yumi Kawata¹, Takeo Morooka¹, Sunao Fujioka¹, Naoyuki Takaki² (1. Japan Medical Isotope K.K., 2. TOKYO CITY UNIVERSITY )

3:15 PM - 3:30 PM

[1D12] Medical RI production using domestic nuclear infrastructures for self-sustenance

(3)Concept study of Mo/Tc production using PWR power plant

*Shizuka Takahashi¹, Takashi Nakahara¹, Shinichi Tsuburaya¹, Kazuta Kobayashi¹, Takuya Nasu¹, Naoyuki TAKAKI² (1. MHI, 2. TCU)

3:30 PM - 3:45 PM

[1D13] Medical RI production using domestic nuclear infrastructures for self-sustenance

(4)Experimental consideration of ⁹⁹Mo / ^99mTc production process

*Kaori Nishikata¹, Yoshitaka Fujita¹, Misaki Seki¹, Tomoaki Takeuchi¹, Hiroshi Ide¹, Kunihiko Tsuchiya¹, Naoyuki Takaki² (1. JAEA, 2. TCU)

Time reserved for Chair (3:45 PM - 3:50 PM)

Session information

[1D10-13] Medical RI Production 1

[1D10] Medical RI production using domestic nuclear infrastructures for self-sustenance

(1)Overall scope and plan

[1D11] Medical RI production using domestic nuclear infrastructures for self-sustenance

(2)Japan market size estimation on Ac225 radiopharmaceuticals

[1D12] Medical RI production using domestic nuclear infrastructures for self-sustenance

(3)Concept study of Mo/Tc production using PWR power plant

[1D13] Medical RI production using domestic nuclear infrastructures for self-sustenance

(4)Experimental consideration of ⁹⁹Mo / ^99mTc production process

Authentication

Session information

[1D10-13] Medical RI Production 1

[1D10] Medical RI production using domestic nuclear infrastructures for self-sustenance

(1)Overall scope and plan

[1D11] Medical RI production using domestic nuclear infrastructures for self-sustenance

(2)Japan market size estimation on Ac225 radiopharmaceuticals

[1D12] Medical RI production using domestic nuclear infrastructures for self-sustenance

(3)Concept study of Mo/Tc production using PWR power plant

[1D13] Medical RI production using domestic nuclear infrastructures for self-sustenance

(4)Experimental consideration of 99Mo / 99mTc production process

Authentication

(4)Experimental consideration of ⁹⁹Mo / ^99mTc production process